Phalanx Metformin 500mg

Description

Phalanx Metformin 500mg is pharmaceutical-grade AMPK activation — the foundational metabolic compound that underpins insulin sensitivity management, blood glucose optimisation, and longevity-focused health protocols. Metformin’s primary mechanism is complex I inhibition in the hepatic mitochondrial electron transport chain, which activates AMPK — the master metabolic switch that drives glucose uptake in skeletal muscle, suppresses hepatic gluconeogenesis, and improves peripheral insulin sensitivity. At 500mg, this is the standard starting dose — well-tolerated, effective, and the basis for titration to 1000–2000mg for more comprehensive metabolic management. For athletes running caloric surpluses, using anabolics that impact insulin sensitivity, or incorporating GH and insulin into their protocols, Metformin provides metabolic buffering that can meaningfully improve nutrient partitioning. Its longevity credentials — supported by the TAME (Targeting Aging with Metformin) trial — make it a compound of growing interest beyond pure performance. Verified at 99%+ purity by Puralytix. Emerging longevity research positions Metformin as one of the few compounds with genuine evidence for extending healthy lifespan through AMPK activation, mTOR modulation, and mitochondrial pathway regulation. For athletes, it serves as metabolic infrastructure — improving the hormonal and metabolic environment in which anabolic compounds work. A daily compound for those taking a comprehensive approach to health alongside performance.